The lab’s recent article in Blood (online only, first edition) was put into context in a news article highlighting how the lab translated cytokine-induced memory-like (CIML or ML) NK cell therapy to treat leukemia in clinical trials, and then built upon this foundation to now engineer new approaches with the promise to treat normally NK cell-resistant cancers!
